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Abstract. 
 
Integrin-associated protein (CD47) is a mul-
tiply membrane spanning member of the immunoglob-
ulin superfamily that regulates some adhesion-depen-
dent cell functions through formation of a complex with 
 
a
 
v
 
b
 
3 integrin and trimeric G proteins. Cholesterol is 
critical for the association of the three protein compo-
nents of the supramolecular complex and for its signal-
ing. The multiply membrane spanning domain of IAP is 
required for complex formation because it binds cho-
lesterol. The supramolecular complex forms preferen-
tially in glycosphingolipid-enriched membrane do-
mains. Binding of mAb 10G2 to the IAP Ig domain, 
previously shown to be required for association with 
 
a
 
v
 
b
 
3, is affected by both the multiply membrane span-
ning domain and cholesterol. These data demonstrate 
that cholesterol is an essential component of the 
 
a
 
v
 
b
 
3/
IAP/G protein signaling complex, presumably acting 
through an effect on IAP conformation.
Key words: cholesterol • integrin • cell adhesion • 
plasma membrane • vitronectin
 
T
 
he
 
 plasma membrane contains specialized glyco-
sphingolipid and cholesterol enriched domains that
may regulate cell surface receptor signal transduc-
tion via the segregation of membrane constituents (re-
viewed in Simons and Ikonen, 1997; Hooper, 1998; Oka-
moto et al., 1998). These membrane domains, which can
be purified because of their low density and resistance to
solubilization by nonionic detergents and are therefore
called detergent-insoluble glycolipid domains (DIGs)
 
1
 
, are
enriched in glycosylphosphatidylinositol (GPI)-linked and
palmitoylated membrane proteins, as well as acylated in-
tracellular signaling molecules. It has been suggested that
these DIGs are especially efficient at initiating signal
transduction. However, the alternative hypothesis, that
they represent sites where signaling molecules can be se-
questered away from signaling stimuli, has been advanced
as well (Rodgers and Rose, 1996).
The integrin-associated protein (IAP, CD47) is a widely
expressed 50-kD protein which is comprised of an extra-
cellular immunoglobulin variable domain, a domain con-
taining five membrane spanning segments, and a cytoplas-
mic tail that can exist in four alternatively spliced forms
(Lindberg et al., 1993; Reinhold et al., 1995). IAP was ini-
tially identified through copurification with the integrin
 
a
 
v
 
b
 
3 from human placenta (Brown et al., 1990) and was
later shown to be identical to CD47 (Lindberg et al., 1994).
IAP has a role in multiple 
 
a
 
v
 
b
 
3-integrin mediated func-
tions, such as binding to vitronectin (Vn)-coated beads
(Lindberg et al., 1996b), PMN activation by Arg-Gly-Asp
(RGD)-containing ligands (Gresham et al., 1992; Senior et
al., 1992; Van Strijp et al., 1993; Zhou and Brown, 1993),
the increase of intracellular calcium in endothelial cells
during adhesion to fibronectin (Schwartz et al., 1993), and
integrin cross-talk (Van Strijp et al., 1993; Blystone et al.,
1994). Absence of IAP leads to a host defense defect man-
ifest as increased susceptibility to 
 
Escherichia coli 
 
infec-
tion because of deficient leukocyte migration to and acti-
vation at the site of infection (Lindberg et al., 1996a).
 
a
 
v
 
b
 
3-mediated activation also is lacking in IAP-deficient
PMN, demonstrating a requirement for IAP in this sig-
naling event. Nonetheless, 
 
a
 
v
 
b
 
3-mediated adhesion and
spreading of many cells is normal in the absence of IAP
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(Lindberg et al., 1993, 1996b), suggesting that IAP regu-
lates only a subset of 
 
a
 
v
 
b
 
3-mediated functions. Further-
more, IAP and 
 
a
 
v
 
b
 
3 differ from some other supramolecu-
lar receptor signaling complexes because each can be
expressed at the plasma membrane without complex as-
sembly, suggesting that both complexed and independent
molecules may exist simultaneously on the same plasma
membrane, thus increasing the potential complexity of
mechanisms of regulation of signaling by IAP and 
 
a
 
v
 
b
 
3.
IAP also is a receptor for thrombospondin (TSP), recog-
nizing the FYVVM sequence present in all TSP isoforms
(Gao et al., 1996b). Through IAP, TSPs can modulate the
function of 
 
a
 
v
 
b
 
3 on endothelial and melanoma cells (Gao
et al., 1996a), 
 
a
 
IIb
 
b
 
3 on platelets (Chung et al., 1997), and
 
a
 
2
 
b
 
1 on smooth muscle cells (Wang and Frazier, 1998).
Recently, heterotrimeric G proteins have been identified
as a third component of the 
 
a
 
v
 
b
 
3/IAP signaling complex
(Frazier et al., 1999), and TSP binding to IAP affects inte-
grin function through a pertussis-toxin sensitive Gi-depen-
dent mechanism (Gao et al., 1996a). However, the molec-
ular pathway through which IAP ligation affects the
function of 
 
a
 
v
 
b
 
3 or any other integrin has not been deter-
mined. Here, we show that the multimolecular complex
among 
 
a
 
v
 
b
 
3, IAP, and G proteins requires cholesterol for
physical assembly and signal transduction and occurs pref-
erentially in DIGs. Cholesterol interacts with IAP and af-
fects its antigenicity, presumably inducing a conformation
favorable to complex formation. These data implicate cho-
lesterol as a fourth component of this supramolecular sig-
naling complex, required for assembly of the proteins into
an effective initiator of signal transduction. Signaling by
this multimolecular membrane complex is thus closely as-
sociated with DIGs localization.
 
Materials and Methods
 
Cells, Antibodies, and Materials
 
The C32 human melanoma cells (American Type Culture Collection) and
the human ovarian carcinoma OV10 cells were maintained as described
(Gao et al., 1996a; Lindberg et al., 1996b). The following mAbs were used
in this study: 2D3, B6H12, 2B7, 1F7, and 10G2 (anti-IAP, CD47; Brown et
al., 1990); MAR4 (anti-
 
b
 
1, CD29; PharMingen); 7G2 and 1A2 (anti-
 
b
 
3,
CD61; Brown and Goodwin, 1988); P1F6 (anti-
 
a
 
v
 
b
 
5; Wayner et al., 1991);
and anti-G
 
b
 
 (Upstate Biotechnology Inc.). Vn was prepared as described
(Blystone et al., 1994). The amino acid sequence of the IAP-binding TSP-
derived peptide 4N1K peptide is KRFYVVMWKK; it was synthesized as
previously described (Kosfeld and Frazier, 1992, 1993).
 
Cell Lysis and Equilibrium Centrifugation
 
mAbs were iodinated using Iodobeads (Pierce Chemical Co.). Cells were
preincubated with saturating levels of 
 
125
 
I-labeled mAbs in RPMI-1640
with 10% FCS for 30 min on ice, followed by extensive washing to remove
excess antibody. Preliminary experiments including 200-fold excess unla-
beled antibody showed that 
 
.
 
98% of the bound radioactivity represented
specific binding. Cells were lysed in 20 mM Tris-HCl, pH 8.2, 140 mM
NaCl, 2 mM EDTA, 25 
 
m
 
g/ml aprotinin, 25 
 
m
 
g/ml leupeptin, 1 mM PMSF,
and 0.5% vol/vol Brij58 for 10 min on ice, homogenized using 10 strokes
of a Dounce homogenizer, then lysed 20 min more on ice. The resulting ly-
sate was adjusted to 40% wt/wt sucrose and applied onto a 60% wt/wt su-
crose cushion. A sucrose step-gradient consisting of 25% wt/wt sucrose
and 5% wt/wt sucrose were layered on top of the lysate. Gradients were
centrifuged 16–20 h at 170,000 
 
g
 
 at 4
 
8
 
C in a SW55 rotor (Beckman Instru-
ments, Inc.). Fractions (0.5 ml) were taken from the top of the gradient us-
ing an auto densi-flow gradient harvester (Labconco). The amount of 
 
125
 
I
present in each fraction was measured using a Packard Crystal II 
 
g
 
counter. Sucrose solutions were made in buffer containing 20 mM Tris-
HCl, pH 8.2, 140 mM NaCl, and 2 mM EDTA. Sucrose density was deter-
mined by refractive index using a refractometer. The amount of protein in
each fraction was determined using the BCA Protein Assay Kit (Pierce
Chemical Co.).
 
Isolation of the Supramolecular Complex
 
Vn or peptides were coupled to 4.5-
 
m
 
m tosyl-activated magnetic beads
and mAb were coupled to sheep anti–mouse 4.5-
 
m
 
m magnetic beads (Dy-
nal) as described by the manufacturer. Cells were resuspended in HBSS
with 0.1 mM MnCl
 
2
 
. Substrate-coated magnetic beads were added to the
cells and the sample was rotated for 15 min at 37
 
8
 
C. Cells bound to the
magnetic beads were collected by placing the sample in a magnet. Lysis
buffer (20 mM Hepes, pH 7.5, 0.1 mM MnCl
 
2
 
, 250 mM sucrose, 25 
 
m
 
g/ml
aprotinin, 25 
 
m
 
g/ml leupeptin, 1 mM PMSF, and 10 mM CHAPS) was
added and the sample was incubated with agitation for 10 min at 37
 
8
 
C.
Magnetic beads were resuspended and incubated 5 min in HBSS with 3
mM MgCl
 
2
 
 and 2.5 units DNase I. 2
 
3
 
 SDS-PAGE sample buffer was
added and the samples were heated for 10 min at 65
 
8
 
C. The samples were
analyzed by SDS-PAGE and Western blotting.
 
Alteration of Plasma Membrane Cholesterol Content 
Using Methyl-
 
b
 
-Cyclodextrin
 
Cells were resuspended at 2.5 
 
3
 
 10
 
5
 
 cells/ml in RPMI/0.1% fatty acid-free
BSA (Sigma Chemical Co.) with or without 5–15 mM methyl-
 
b
 
-cyclodex-
trin (M
 
b
 
CD; Aldrich Chemical Co.) and incubated 15 min at 37
 
8
 
C. After
washing, cells were added to the prepared tissue culture wells and allowed
to spread 30 min to 1 h at 37
 
8
 
C. Cholesterol was reintroduced into cells us-
ing 1.33 mg/ml cholesterol-M
 
b
 
CD inclusion complexes in RPMI/0.1%
fatty acid-free BSA, which results in a 0.1 mM solution of cholesterol
(Klein et al., 1995). To quantitate the amount of cholesterol in membranes
after these treatments, cellular lipids were extracted by the method of
Bligh and Dyer (1959), and cholesterol content was assayed by the choles-
terol oxidase method (Wako Chemicals USA). Approximately 30% of
cellular cholesterol was removed in OV10 cells by this treatment.
 
Preparation of Cholesterol-Methyl-
 
b
 
-Cyclodextrin 
Inclusion Complexes
 
Cholesterol-M
 
b
 
CD inclusion complexes were prepared as described
(Klein et al., 1995). In brief, a solution of 30 mg cholesterol (Sigma Chem-
ical Co.) in 400 
 
m
 
l 2:1 vol/vol methanol/chloroform was added drop-wise
to a stirred solution of 1 g of M
 
b
 
CD in 11 ml PBS prewarmed in an 80
 
8
 
C
waterbath. The solution was stirred at 80
 
8
 
C until a clear solution resulted.
The cholesterol-M
 
b
 
CD inclusion complexes were used immediately or
freeze-dried. Inclusion complexes of the steroid analogues were made
similarly using 30 mg 5-cholestene-3-one, 20 mg 5-cholestene, or 24.7 mg
pregnenolone.
 
Cell Spreading Assay
 
IAP-enhanced spreading of C32 cells on suboptimal doses of Vn was per-
formed as described (Gao et al., 1996a). In brief, 12-well plates (Costar
Corp.) were coated for 2 h at room temperature with 0.125 
 
m
 
g/ml Vn in
HBSS. Plates were blocked with 1% BSA/PBS for 2 h at room tempera-
ture and washed three times with PBS. After M
 
b
 
CD treatment, C32 cells
were plated in HBSS with 1 mM CaCl
 
2
 
 and 1 mM MgCl
 
2
 
 with or without
the addition of 20 
 
m
 
M 4N1K peptide. M
 
b
 
CD inclusion complexes made
with cholesterol or the steroid analogues were added to some wells. Cells
were allowed to spread for 30 min at 37
 
8
 
C.
 
FACS
 
®
 
 Staining
 
Indirect immunofluorescence was analyzed on OV10 cells with or without
pretreatment with M
 
b
 
CD as described (Rosales et al., 1992). The primary
antibodies used were 10G2, a murine mAb that detects a subset of IAP on
some cells (Hermann et al., 1999), and 1F7, a murine mAb that detects all
IAP (Brown et al., 1990). FITC-labeled antimurine 
 
m
 
 chain and antimu-
rine 
 
g
 
 chain (Sigma Chemical Co.) was used to detect cell-bound 10G2
and 1F7, respectively.  
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Results
 
Cholesterol Is Required For IAP/
 
a
 
v
 
b
 
3/G
Protein Complex
 
Previous studies using liposomes reconstituted with 
 
a
 
v
 
b
 
3
showed that lipid composition affected ligand binding by
this integrin and that a cholesterol-containing environ-
ment markedly enhanced ligand binding (Conforti et al.,
1990). Ligand binding by 
 
a
 
v
 
b
 
3 also is influenced by IAP
(Gresham et al., 1992; Lindberg et al., 1996b). Because
IAP likely contaminated the 
 
a
 
v
 
b
 
3 used to prepare the
liposomes, we determined whether cholesterol affected
 
a
 
v
 
b
 
3 association with IAP. Trimeric G proteins have been
identified as a signal transduction component associated
with IAP and 
 
a
 
v
 
b
 
3 (Frazier et al., 1999). 
 
a
 
v
 
b
 
3/IAP/G pro-
tein complexes were isolated from OV10 cells express-
ing both 
 
b
 
3 integrin and IAP (Lindberg et al., 1996b), and
treated in vitro with the cholesterol-chelating agent M
 
b
 
CD
(Klein et al., 1995; Gimpl et al., 1997; Keller and Simons,
1998). Treatment with M
 
b
 
CD markedly decreased associ-
ation of both IAP and G
 
b with the purified avb3 (Fig. 1
A). Anti-Ga Western blots showed a similar decrease in
Ga association with avb3 (Fig. 1 A). Thus, removal of
cholesterol compromised association of avb3 with IAP
and trimeric G protein. No caveolin was identified in these
isolated complexes, although OV10 cells do express caveo-
lin (data not shown). No avb3, IAP, or G protein was pre-
cipitated with YIGSR-coated beads (Fig. 1 A). These con-
trol beads bind to a nonintegrin laminin receptor (Graf et
al., 1987a) expressed on OV10 cells.
Cholesterol also was required for complex assembly in
intact cells, since little associated IAP or G protein was
copurified with avb3 isolated from OV10 cells treated
with MbCD (Fig. 1 B). Whereas MbCD removes choles-
terol from cell membranes, MbCD–cholesterol inclusion
complexes mediate the incorporation of cholesterol into
membranes (Klein, et al. 1995). Treatment of OV10 cells
with MbCD decreased cell cholesterol content 30–40%;
subsequent incubation with MbCD-cholesterol inclusion
complexes restored cellular cholesterol to basal levels
(data not shown). In cells treated first with MbCD to dis-
assemble the integrin/IAP/G protein signaling complexes
Figure 1. Cholesterol is in IAP/avb3/G pro-
tein complexes. A, Complexes of avb3, IAP,
and G proteins from avb3- and IAP-express-
ing OV10 cells were isolated using beads
coated with the avb3 ligand, RGDS, as de-
scribed in Materials and Methods, then
treated in vitro with buffer or 1 mM MbCD,
and finally analyzed by SDS-PAGE and
Western blotting using the b3 specific mAb
7G2, the IAP specific mAb B6H12, or rabbit
antibodies specific for Ga or Gb. Identical re-
sults were obtained with complexes obtained
with Vn-coated beads or with anti-avb3–
coated beads (data not shown). No protein
reactive with any of the detecting antibodies
was obtained using beads coated with the cell
binding laminin peptide, YIGSR (Iwamoto et
al., 1987) that does not bind integrins (Graf et
al., 1987b). B, Coimmunoprecipitations were
performed using beads coated with the b3
specific mAb 1A2 from buffer treated (lane
1), cholesterol-depleted (lane 2), or choles-
terol-repleted (lane 3) OV10 cells expressing
avb3 and IAP. Cholesterol depletion with
MbCD and repletion with MbCD-cholesterol
complexes were performed as described in
Materials and Methods. No protein was im-
munoprecipitated using the irrelevant mAb
543 (data not shown). C, Structures of the
cholesterol analogues used for preparation of
the MbCD inclusion complexes. D, Coimmu-
noprecipitations were performed using beads
coated with the b3 specific mAb 1A2 from
cholesterol-depleted cells repleted with cho-
lesterol or one of the analogues, 5-choles-
tene-3-one, 5-cholestene, or pregnenolone.
Western blotting for IAP is shown. The
amount of avb3 immunoprecipitated was
similar for each sample, as determined by
Western blotting (data not shown). Each ex-
periment is representative of at least three
repetitions.The Journal of Cell Biology, Volume 146, 1999 676
and then incubated with cholesterol-charged MbCD to re-
store membrane cholesterol, IAP/avb3/G protein com-
plexes were isolated to the same extent as in untreated
cells (Fig. 1 B).
To examine the structural requirements for cholesterol
in complex formation, inclusion complexes were made
with several cholesterol analogues. Steroids with minimal
structural differences to cholesterol were chosen, all hav-
ing the hydrophobic, planar, core ring structure (Fig. 1 C).
5-cholestene lacks the 3b-hydroxyl group. Pregnenolone
contains a methyl ketone group instead of the aliphatic
tail. A carbonyl replaces the 3b-hydroxyl group in 5-cho-
lestene-3-one. These compounds yield an equilibrium be-
tween MbCD-complexed steroid and steroid incorporated
into the plasma membrane, similar to what is observed
with cholesterol itself (Klein et al., 1995). Neither 5-cho-
lestene nor pregnenolone was able to restore association
of IAP/avb3/G protein complexes in MbCD treated cells
(Fig. 1 D). However, 5-cholestene-3-one was even better
than cholesterol (z2.3-fold better by densitometry) in re-
storing the IAP/avb3 association. Thus, there is structural
specificity in the lipid requirement for complex formation,
with both the aliphatic tail and an oxygen in the 3 position
of the cholestene ring apparently required.
Cholesterol Is Required for IAP-avb3 Signaling 
To determine the role for the cholesterol-dependent su-
pramolecular complex in IAP/avb3 signaling, we exam-
ined the role of the complex in TSP modulation of avb3
function in C32 cells. This is an excellent model to test sig-
naling by the complex since the COOH-terminal domain
of TSP (TSP-1) has been shown to modulate avb3 in-
tegrin-mediated adhesion and spreading of these cells
through interaction with IAP, and this effect requires acti-
vation of a heterotrimeric G protein (Gao et al., 1996a;
Figure 2. Effect of cholesterol depletion on spreading and tyrosine phosphorylation
of C32 melanoma cells. (A–D, G–I) C32 cells were allowed to spread on plates
coated with a suboptimal amount of Vn (0.125 mg/ml) for 30 min at 378C in the ab-
sence (A) or presence (B–D, G–I) of 20 mM TSP peptide 4N1K in solution. C, Cells
were pretreated with 10 mM MbCD for 15 min to remove plasma membrane choles-
terol. D, Cholesterol–MbCD inclusion complexes were added to cholesterol-
depleted cells to replenish plasma membrane cholesterol. E and F, Cells spreading
on plates coated with 1 mg/ml Vn in the absence (E) or presence (F) of 10 mM
MbCD. No 4N1K peptide was added. Spreading was complete within 30 min at 378C,
when pictures were taken. G–I, Cholesterol-depleted cells were treated with 4N1K
peptide and MbCD-inclusion complexes made with the cholesterol analogues 5-cho-
lestene-3-one (G), 5-cholestene (H), and pregnenolone (I). 5-cholestene-3-one inhib-
ited C32 spreading on high (1 mg/ml) Vn, demonstrating a nonspecific inhibition of
cell spreading, but the other two analogues had no such effect (data not shown). J,
C32 cells, with or without treatment with 10 mM MbCD, were incubated on low den-
sity Vn (0.125 mg/ml) in the absence or presence of 20 mM 4N1K or the scrambled
control peptide 4NGG (Gao et al., 1996b). Alternatively, cells were allowed to spread on high concentrations of Vn (1 mg/ml). After cell
lysis and SDS-PAGE, Western blotting was performed using antiphosphotyrosine mAb 4G10.Green et al. Cholesterol in IAP Signaling 677
Frazier et al., 1999). Moreover, cholesterol depletion re-
sulted in no loss of viability and no obvious morphologic
change in these cells (data not shown). Only when C32
cells were treated with the IAP-binding agonist peptide
from TSP-1 (4N1K; Kosfeld and Frazier, 1993; Gao et al.,
1996b) did they spread on surfaces coated with low con-
centrations of Vn (Fig. 2, A and B; Gao et al., 1996b), an
effect abolished by cholesterol chelation with MbCD (Fig.
2 C). Cholesterol repletion using MbCD inclusion com-
plexes restored IAP-dependent spreading (Fig. 2 D). In
contrast, MbCD had no effect on C32 spreading on high
density Vn (Fig. 2, E and F), which is known to be IAP-
independent (Gao et al., 1996a). None of the cholesterol
analogues were able to restore 4N1K-induced spreading in
MbCD treated cells (Fig. 2, G–I). The failure of 5-choles-
tene-3-one, which restores complex formation, to restore
TSP induction of C32 cells spreading, resulted from a gen-
eral inhibition of cell spreading by this cholesterol ana-
logue, since C32 spreading on high concentration Vn was
inhibited in cells repleted with this cholesterol analogue
(data not shown). In contrast, neither 5-cholestene nor
pregnenolone affected C32 spreading on high Vn sub-
strates. Thus, cholesterol is required for cooperation be-
tween IAP and avb3 in C32 cells, but not for cell spread-
ing in general.
While cell spreading in response to 4N1K likely requires
IAP-dependent signal transduction, the biochemical medi-
ators of this signaling are not known (Gao et al., 1996a).
Therefore, we measured 4N1K-mediated inhibition of ad-
enylate cyclase in prostaglandin E1 (PGE1)-treated resting
platelets, an event known to require heterotrimeric G pro-
tein signaling (Frazier et al., 1999). 4N1K caused an 80%
decrease in cAMP levels in platelets (81.4 6 5.2 fmol/2 3
107 cells to 16.0 6 3.2). In MbCD-treated platelets, the
cAMP was unchanged by 4N1K (33.4 6 3.3 fmol without
and 31 6 3.2 with 4N1K). Repletion of cholesterol in
MbCD-treated platelets allowed 4N1K to again induce a
drop in cAMP to 18 6 2.4 fmol, not different from the
cAMP in 4N1K-treated platelets without cholesterol per-
turbation. The reason that MbCD caused a decrease in the
basal level of cAMP in resting platelets is unknown, but
may reflect a failure of PGE1 signaling, since it binds to a
seven transmembrane Gs-coupled receptor that likely re-
sides in DIGs (Kerins et al., 1991; Woodward et al., 1997).
Removal of cholesterol did not abolish all cell signaling
since tyrosine phosphorylation in response to both 4N1K
treatment and adhesion to high concentrations of Vn was
normal in MbCD treated cells (Fig. 2 J). Thus, while cho-
lesterol depletion by MbCD does not affect integrin-
dependent tyrosine phosphorylation, it does block 4N1K-
initiated spreading and signaling, which are dependent on
heterotrimeric G proteins.
IAP/avb3/G Protein Complex Requires the IAP 
Multiply Membrane Spanning Domain and 
Extracellular Domain
To determine how cholesterol affected assembly of the su-
pramolecular signaling complex, we determined the role
of the IAP multiply membrane spanning (MMS) domain
and extracellular domain in complex formation. avb3 inte-
grins were isolated from transfected OV10 cells expressing
normal IAP, IAP in which the MMS domain had been re-
placed either by a single pass CD7 transmembrane domain
(IAP/CD7) or by a glycan phosphoinositol anchor (IAP/
GPI), or IAP in which the extracellular domain of IAP
was replaced with a FLAG epitope (MC2). The IAP Ig
domain was expressed equivalently on OV10 cells trans-
fected with each of the Ig domain-expressing constructs
(Lindberg et al., 1996b) and the MMS domain was equiva-
lently expressed in wild-type and IAP/MC2 transfected
cells, as assessed by antibody against the IAP cytoplasmic
tail (data not shown). While the complex was easily iso-
lated using either the avb3 ligand Vn or anti-b3 mAb
(1A2) from cells expressing normal IAP, minimal IAP or
G protein was copurified with integrin from cells express-
ing either IAP/CD7, IAP/GPI, or IAP/MC2 (Fig. 3). Fur-
thermore, the IAP MMS domain influenced cholesterol
association with avb3, since there was 1.7 6 0.85-fold (P ,
0.03, n 5 4) more cholesterol associated with anti-b3 1A2
immunoprecipitates from OV10 cells expressing IAP than
from cells deficient in IAP. In addition, there was 2.1 6
0.46-fold (P , 0.03, n 5 3) more cholesterol associated
with anti-IAP immunoprecipitates from OV10 cells ex-
pressing wild-type IAP than from cells expressing either
IAP/GPI or IAP/CD7. Thus, both the MMS and the Ig do-
mains of IAP are required for complex assembly, and the
MMS domain enhances cholesterol association with the
avb3 integrin.
IAP/avb3/G Protein Complex Is Preferentially
Formed in DIGs
Because cholesterol and heterotrimeric G proteins are
concentrated in DIGs in many cell types (Brown and
Rose, 1992; Sargiacomo et al., 1993), it was possible that
the IAP-dependent signaling complex was preferentially
formed in these domains. Sucrose density ultracentrifuga-
Figure 3. Requirement of the IAP MMS domain for supramolec-
ular complex formation. avb3 was isolated from OV10 cells ex-
pressing wild-type IAP, IAP/CD7, IAP/GPI, or IAP/MC2 using
beads coated with the avb3 ligand Vn or the anti-b3 mAb 1A2.
Samples were analyzed by SDS-PAGE and Western blotting us-
ing the b3 specific mAb 7G2, the IAP specific mAb B6H12, or
rabbit antibodies specific for Gb. mAb 131, specific for the cyto-
plasmic tail of IAP, was used to probe for IAP/MC2. Similar re-
sults were obtained using beads coated with the b3 ligand, RGDS
(data not shown).The Journal of Cell Biology, Volume 146, 1999 678
tion demonstrated that both avb3 and IAP were enriched
in DIGs, which are found at the interface of the 25 and 5%
sucrose layers (Fig. 4, fractions 7–9). Approximately half
of IAP (Fig. 4 A) was isolated in this low density mem-
brane fraction, together with about one-fourth of the avb3
(Fig. 4 B). In contrast, the closely related avb5 integrin lo-
calized predominantly to the bulk membranes (Fig. 4 C,
fractions 2–4), together with .95% of total cellular pro-
tein (Fig. 4 D). To determine whether complex formation
occurred preferentially among the IAP, avb3, and G pro-
teins in DIGs, avb3 was purified from individual fractions
of the sucrose gradient and coassociation of avb3, IAP,
and heterotrimeric G proteins determined (Fig. 4 E). To-
gether with 15% of the bead-bound avb3 (as determined
by densitometry), z40% of the associated IAP and Gb
were coprecipitated in the DIGs. This represents a mini-
mum estimate of DIGs-associated complex, since the puri-
fication procedure was presumably not 100% efficient.
Thus,  avb3 in DIGs was at least four times more likely to
be involved in complex formation than avb3 in the bulk
membrane fractions of the cell, demonstrating a preferen-
tial association of the complex with DIGs. To determine
whether complex formation was required for localization
of IAP or avb3 to DIGs, fractionation studies were per-
formed on cells lacking IAP or avb3. In OV10, avb3 local-
ized to DIGs similarly whether or not IAP was present
(Fig 4 B). In the Jurkat T lymphoid line, which expresses
little if any avb3 (Reinhold et al., 1997) and as a conse-
quence have no detectable avb3/IAP complex, .60% of
the IAP was in low density fractions (data not shown).
Thus, IAP and avb3 localize to DIGs independent of com-
plex formation. It is already known that trimeric G pro-
teins localize to DIGs because of acylation and/or interac-
tion with caveolin (Sargiacomo et al., 1993; Couet et al.,
Figure 4. DIGs localization of
components of the signaling
complex. Specific radioactivity
in sucrose density fractions ob-
tained from OV10 cells labeled
with 125I mAbs specific for IAP
(mAb 2B7; A), avb3 (mAb
1A2; B), or avb5 (mAb P1F6;
C) are shown. Data is presented
as a percentage of the total input
counts in each fraction. In B,
distribution of radioactivity in
cells with and without IAP are
compared. D, Distribution of to-
tal protein, measured by the
BCA assay. The sucrose concen-
tration is highest in fraction 1
and least in fraction 10.  P  de-
notes radioactivity or protein in
the pellet. DIGs migrate to the
interface of the 25 and 5% su-
crose solutions (fraction 7–9),
while the vast majority of mem-
brane protein is contained
within the 40% sucrose frac-
tions. Data is representative of
three or more experiments. E
and F, avb3 was immunoprecip-
itated with mAb 1A2 from each
fraction of a sucrose density gra-
dient prepared with unlabeled
OV10 cells expressing wild-type
IAP. The samples were ana-
lyzed by SDS-PAGE and West-
ern blotting using anti-b3 mAb
7G2 and anti-IAP mAb B6H12
(E) or anti-b3 and rabbit anti-
bodies specific for Gb (F).Green et al. Cholesterol in IAP Signaling 679
1997; Mumby, 1997). Thus, each of the three protein com-
ponents of the complex is targeted to DIGs independent
of complex formation, suggesting that DIGs are the mem-
brane sites where these signaling complexes form.
DIGs Localization Is Not Sufficient for
Complex Formation
To determine the effect of cholesterol removal on localiza-
tion of the protein components of the complex to DIGs,
OV10 were treated with MbCD before sucrose density
gradient centrifugation. The localization of IAP was mini-
mally affected by MbCD treatment (Fig. 5 A). However,
both avb3 (Fig. 5 B) and Gb (Fig. 5 C) localization were
substantially diminished (Fig. 5 D). To determine if DIGs
localization of each of the components was sufficient for
complex formation, the membrane localization of IAP/
CD7 (Fig. 5 E) and IAP/GPI (Fig. 5 F), both of which
failed to form complexes, was determined. While less IAP/
CD7 was in DIGs, IAP/GPI localized to the DIGs to a
similar extent to wild-type IAP (see Figs. 4 A and 5A).
This is consistent with the known propensity of GPI-
linked proteins to be enriched in DIGs (Brown and Rose,
1992; Sargiacomo et al., 1993; Friedrichson and Kurzcha-
lia, 1998; Varma and Mayor, 1998). Since complexes did
not form in cells expressing IAP/GPI (Fig. 3) despite the
ability of the IAP Ig domain to mediate interaction with
avb3 (Lindberg et al., 1996b), this result demonstrates that
localization of the IAP Ig domain to DIGs is not sufficient
for complex formation and that the MMS domain of IAP
must serve another function in complex formation. Fur-
thermore, this experiment demonstrates that the protocol
for isolating the avb3/IAP/G protein complex does not
simply nonspecifically copurify all proteins found in DIGs.
However, DIGs localization of each component of the
complex may be necessary for complex formation. Since
cholesterol is an essential component of the complex,
DIGs localization may provide a mechanism for focusing
Figure 5. Effect of cholesterol
depletion on DIGs localization
of signaling components. A–D,
OV10 cells expressing IAP
treated with or without 10 mM
MbCD before Brij lysis and
sucrose density centrifugation.
Distribution of 125I-labeled anti-
IAP mAb 2B7 (A) or anti-b3
mAb 1A2 (B) was determined
as described in Fig. 4. C, Bulk
membranes (fractions 2–4 com-
bined from a sucrose gradient)
and DIGs containing fractions
(fractions 7–9 combined) were
analyzed by SDS-PAGE and
Western blotting using rabbit
antibodies specific for Gb after
sucrose density fractionation of
unlabeled cells. D, The percent
of IAP, b3, and Gb remaining in
the DIGs-containing fractions
7–9 after MbCD treatment. Per-
centage of total counts was used
to determine the amount of IAP
or b3 present, and densitometry
of Western blots was used to
determine the amount of Gb
present. E and F, Distribution of
IAP Ig domain-expressing mole-
cules after sucrose density cen-
trifugation of Brij-lysed OV10
cells expressing IAP/GPI (E) or
IAP/CD7 (F) was determined as
described in Fig. 4.The Journal of Cell Biology, Volume 146, 1999 680
the proteins of the complex at a site where an adequate
concentration of cholesterol exists for complex assembly.
Cholesterol Affects IAP Expression of the 10G2 Epitope
A previous study suggested that the interaction between
IAP and avb3 could occur through the IAP Ig domain
(Lindberg et al., 1996b). Thus, it was possible that choles-
terol interaction with the IAP MMS domain could affect
the IAP conformation to facilitate complex formation. To
determine whether any cholesterol-dependent conforma-
tion of IAP could be discovered, FACS® analysis was per-
formed with 10G2, a mAb that recognizes only a subset of
IAP on many cells (Hermann et al., 1999). 10G2 rec-
ognizes the IAP Ig domain, as demonstrated by ELISA
and Western blotting with purified Ig domain (data not
shown). On OV10 cells, 10G2 recognized wild-type IAP
approximately fourfold better than IAP/CD7 and did not
bind IAP/GPI at all (Fig. 6, top). This difference in detec-
tion was not due to differences in expression, as detected
by the conventional anti-IAP mAb B6H12, which detects
equivalent expression of the three constructs (Lindberg et
al., 1996b; data not shown). When OV10 expressing wild-
type IAP were treated with MbCD, 10G2 binding in-
creased another sixfold (Fig. 6, middle). Repletion of cel-
lular cholesterol with MbCD/cholesterol complexes re-
turned 10G2 binding to the level of untreated cells. MbCD
did not affect 10G2 binding to IAP/CD7 or IAP/GPI (data
not shown). Furthermore, MbCD did not affect the bind-
ing of the anti-IAP mAbs 2D3 or 2B7 (Fig. 6, bottom).
These data demonstrate that the availability of the 10G2
epitope on the IAP Ig domain on OV10 cells is markedly
influenced by the MMS domain and is significantly modu-
lated by cholesterol. Its ability to modulate 10G2 binding
to the Ig domain suggests that cholesterol binding to the
IAP MMS domain affects IAP conformation.
Discussion
IAP is a plasma membrane protein first isolated by copuri-
fication with av integrins. Subsequent studies have dem-
onstrated a functional association of IAP with b3 integrins
in leukocytes and endothelial cells (Senior et al., 1992;
Schwartz et al., 1993; Van Strijp et al., 1993; Zhou and
Brown, 1993) and coimmunoprecipitation of IAP with
avb3 from several cells and tissues (Brown et al., 1990).
Moreover, IAP is required for Vn bead binding by both
avb3 and avb5 integrins in OV10 cells (Lindberg et al.,
1996b). However, IAP appears to be unnecessary for
adhesion of these same cells to Vn-coated surfaces and
IAP-deficient mice develop normally, in contrast to av-
deficient mice, demonstrating that IAP is not absolutely
required for av integrin function. This has led to the hy-
pothesis that IAP and avb3 form a signaling complex in at
least some cells that can influence specific cell functions.
Recently, association of avb3 and IAP with trimeric G
proteins has been demonstrated (Frazier et al., 1999), sug-
gesting a mechanism by which the avb3/IAP complex may
signal. However, the molecular mechanisms involved in
association of avb3 with IAP or of this membrane com-
plex with G proteins have not been resolved.
An unusual feature of IAP is its MMS domain, which
could allow for enhanced interactions with and regulation
by membrane lipids. To determine whether this was the
case, we examined whether cholesterol was required for
association of IAP with avb3 integrin and with trimeric G
proteins. Although the removal of cholesterol with MbCD
has been shown to disrupt receptor signaling in a variety of
cells (Fernandez-Ballester et al., 1994; Gimpl et al., 1997;
Xavier et al., 1998; Zhang et al., 1998; Sheets et al., 1999a),
a specific role for cholesterol in the formation of supramo-
lecular receptor complexes or in regulation of integrin
function has not been demonstrated previously. We found
that cholesterol is required both for maintenance of com-
Figure 6. Binding of mAb 10G2 to IAP. Top, OV10 cells ex-
pressing IAP, IAP/GPI, or IAP/CD7 were incubated with the
mAb 10G2. FACS® analysis with anti-IAP mAb B6H12 showed
that both IAP/GPI and IAP/CD7 were expressed at a level at
least equivalent to that of wild-type IAP (mean channel fluores-
cence wild-type IAP, 3.8 6 0.1; IAP/GPI, 6.1 6 0.3; IAP/CD7,
11.7 6 1.4; Lindberg et al., 1996b; data not shown). Middle, 10G2
binding was determined on buffer-treated OV10, cholesterol-
depleted OV10, and cholesterol-repleted OV10 expressing wild-
type IAP. Bottom, Binding of conventional anti-IAP mAb 2D3
and 2B7 (Brown et al., 1990) was determined on buffer-treated and
MbCD-treated OV10 expressing wild-type IAP.Green et al. Cholesterol in IAP Signaling 681
plexes in cells and for maintenance of isolated complexes
in vitro. Thus, cholesterol is the fourth molecular and first
described nonprotein component of this signaling com-
plex. Likely, the cholesterol interacts with the IAP MMS
domain, since replacement with a single transmembrane
domain in IAP/CD7 or with a GPI-anchor in IAP/GPI
abolished complex formation as efficiently as cholesterol
removal. Moreover, removal of cholesterol or replace-
ment of the MMS domain with CD7 also abolished func-
tional responses to IAP ligation in Jurkat T cells and mu-
rine fibroblasts (unpublished data). Thus, cholesterol is
required not only for physical association of IAP with inte-
grins and G proteins, but for integrin-independent func-
tions of IAP as well.
Recently, the understanding has emerged that there are
distinct domains within the lipid bilayer in which specific
lipids are concentrated (Brown and Rose, 1992; Sargia-
como et al., 1993). Because they can be purified and studied
due to their low density and relative resistance to solubili-
zation by some detergents, domains enriched in glycosphin-
golipids and cholesterol are the best characterized
(Brown and Rose, 1992; Sargiacomo et al., 1993). These
domains are called DIGs, GEMs (for glycosphingolipid-
enriched membranes), or rafts, to reflect these properties.
In addition to lipids, these domains are enriched in specific
integral membrane proteins, of which caveolin is the best
known (Kurzchalia et al., 1992). However, it is now clear
that caveolin is not required for organization of the do-
mains and DIGs can exist even in cells lacking caveolin
(Fra et al., 1994). In addition to caveolin, DIGs contain
disproportionately high concentrations of GPI-linked mem-
brane proteins, as well as a variety of cytoplasmic proteins
that associate with the plasma membrane through lipid
modifications, including NH2-terminal myristoylation and/
or palmitoylation (Simons and Ikonen, 1997). In this latter
category are a variety of signal transduction molecules,
such as heterotrimeric G proteins and some src family ki-
nases, which have been shown to localize to these domains
(Xavier et al., 1998). However, the significance of domain
localization is somewhat controversial. While specializa-
tion of these domains as sites for initiation of signal trans-
duction has been proposed (Field et al., 1995; Xavier et al.,
1998; Zhang et al., 1998), so has the opposite, that these
are sites where signal transduction proteins can be seques-
tered in inactive form (Rodgers and Rose, 1996).
IAP and avb3 both preferentially localize to DIGs and
their association is greatly enhanced in these domains.
This may imply that the functional signaling complex lo-
calizes to these membrane domains and that DIGs are es-
sential for signal propagation across the membrane, per-
haps because of proximity to other cytoplasmic molecules
required for the signaling cascade. Alternatively, the local-
ization to DIGs may simply reflect the tight association
with cholesterol that apparently characterizes the com-
plex. However, it is clear that localization to DIGs is not
sufficient for stable physical association, since IAP/GPI,
which localizes to DIGs equally as well as wild-type IAP
does not participate in complex formation. Moreover, re-
moval of cholesterol fails to disrupt localization of IAP to
DIGs, even though the functional association among inte-
grin, IAP, and G proteins is disrupted, and IAP no longer
functions in integrin-mediated spreading. It is possible that
a particularly tight or specific association of IAP with cho-
lesterol would require more extensive depletion of choles-
terol than is achieved with 10 mM MbCD to affect local-
ization.
It is interesting that localization of IAP to DIGs and for-
mation of stable complexes with avb3 and G proteins ap-
pears not to be required for IAP enhancement of av inte-
grin bead binding, since both IAP/CD7 and IAP/GPI can
mediate this effect of IAP (Lindberg et al., 1996b). This
suggests that IAP’s regulation of avb3 ligand binding does
not depend on its signaling capacity, but relies instead on
direct interaction of its Ig domain with av integrins, poten-
tially altering the Vn-binding ability of these integrins. It is
possible that this effect of IAP does not require stable as-
sociation with the integrin and that once Vn binding is ac-
tivated, the avb3 integrin can bind ligand tightly without
IAP (Orlando and Cheresh, 1991). Nonetheless, these ex-
periments suggest that the IAP Ig domain is an important
component of the interaction of IAP with avb3. Consis-
tent with this, no complex formation can be demonstrated
in cells transfected with a chimeric molecule in which the
IAP Ig domain has been replaced with an irrelevant do-
main. Based on these observations, we propose a model in
which the conformation of IAP is influenced by the MMS
domain and further influenced by the tight binding of cho-
lesterol to the MMS domain. This is consistent with the
pattern of binding of the 10G2 mAb to OV10-expressed
IAP, for which the MMS domain is required and mAb
binding enhanced by cholesterol removal. In this model,
the cholesterol-replete conformation of IAP can interact
with avb3, and for this, the Ig domain is required. This en-
tity, in turn, associates with the trimeric G protein to form
the complete signaling complex. Since there is specificity
in the ability of cholesterol analogues to mediate IAP-
avb3 complex formation, it will be interesting to deter-
mine whether the failure of some analogues to mediate
complex formation reflects failure to interact with IAP or
failure to induce the change in IAP conformation and
function.
In summary, we have demonstrated that cholesterol has
a critical role in assembly of the avb3/IAP/G protein sig-
naling complex. This is a novel role for a membrane lipid
and suggests a new and direct mechanism for regulation of
signal transduction by supramolecular complexes in the
plasma membrane. It has been shown that cell activation
signals can regulate the association of the high affinity Fce
receptor with DIGs (Sheets et al., 1999b). It is possible
that IAP association with these cholesterol rich domains
also is regulated and that this, in turn, affects formation
and maintenance of the signaling complex containing
avb3 and heterotrimeric G proteins. 
The authors gratefully acknowledge helpful discussions with Linda Pike
and Maureen Linder (Washington University School of Medicine). 
This work was supported by National Institutes of Health grants
GM38330 and AI24674 (to E.J. Brown), GM54390 (to W.A. Frazier), and
GM57573 (to F.P. Lindberg). J.M. Green was a Markey Foundation Fel-
low during the pursuit of these studies.
Submitted: 27 January 1999
Revised: 6 July 1999
Accepted: 7 July 1999The Journal of Cell Biology, Volume 146, 1999 682
References
Bligh, E.G., and W.J. Dyer. 1959. A rapid method of total lipid extraction and
purification. Can. J. Biochem. Physiol. 37:911–917.
Blystone, S.D., I.L. Graham, F.P. Lindberg, and E.J. Brown. 1994. Integrin al-
pha-v beta-3 differentially regulates adhesive and phagocytic functions of
the fibronectin receptor alpha-5 beta-1. J. Cell Biol. 127:1129–1137.
Brown, D.A., and J.K. Rose. 1992. Sorting of GPI-anchored proteins to gly-
colipid-enriched membrane subdomains during transport to the apical cell
surface. Cell. 68:533–544.
Brown, E.J., and J.L. Goodwin. 1988. Fibronectin receptors of phagocytes:
characterization of the Arg-Gly-Asp binding proteins of human monocytes
and polymorphonuclear leukocytes. J. Exp. Med. 167:777–793.
Brown, E.J., L. Hooper, T. Ho, and H.D. Gresham. 1990. Integrin-associated
protein: a 50-kD plasma membrane antigen physically and functionally asso-
ciated with integrins. J. Cell Biol. 111:2785–2794.
Chung, J., A.G. Gao, and W.A. Frazier. 1997. Thrombospondin acts via inte-
grin-associated protein to activate the platelet integrin aIIbb3. J. Biol. Chem.
272:14740–14746.
Conforti, G., A. Zanetti, I. Pasquali-Ronchetti, D. Quaglino, Jr., P. Neyroz, and
E. Dejana. 1990. Modulation of vitronectin receptor binding by membrane
lipid composition. J. Biol. Chem. 265:4011–4019.
Couet, J., S. Li, T. Okamoto, T. Ikezu, and M.P. Lisanti. 1997. Identification of
peptide and protein ligands for the caveolin–scaffolding domain. Implica-
tions for the interaction of caveolin with caveolae-associated proteins. J.
Biol. Chem. 272:6525–6533.
Fernandez-Ballester, G., J. Castresana, A.M. Fernandez, J.L. Arrondo, J.A.
Ferragut, and J.M. Gonzalez-Ros. 1994. Role of cholesterol as a structural
and functional effector of the nicotinic acetylcholine receptor. Biochem. Soc.
Trans. 22:776–780.
Field, K.A., D. Holowka, and B. Baird. 1995. Fc epsilon RI-mediated recruit-
ment of p53/56lyn to detergent-resistant membrane domains accompanies
cellular signaling. Proc. Natl. Acad. Sci. USA. 92:9201–9205.
Fra, A.M., E. Williamson, K. Simons, and R.G. Parton. 1994. Detergent-insolu-
ble glycolipid microdomains in lymphocytes in the absence of caveolae. J.
Biol. Chem. 269:30745–30748.
Frazier, W.A., A.-G. Gao, J. Dimitry, J. Chung, E.J. Brown, F.P. Lindberg, and
M.E. Linder. 1999. The thrombospondin receptor integrin-associated pro-
tein (CD47) functionally couples to heterotrimeric Gi. J. Biol. Chem. 274:
8554–8560.
Friedrichson, T., and T.V. Kurzchalia. 1998. Microdomains of GPI-anchored
proteins in living cells revealed by crosslinking. Nature. 394:802–805.
Gao, A.-G., F.P. Lindberg, J.M. Dimitry, E.J. Brown, and W.A. Frazier. 1996a.
Thrombospondin modulates alpha v beta 3 function through integrin-associ-
ated protein. J. Cell Biol. 135:533–544.
Gao, A.-G., F.P. Lindberg, M.B. Finn, S.D. Blystone, E.J. Brown, and W.A.
Frazier. 1996b. Integrin associated protein is a receptor for the carboxy ter-
minal domain of thrombospondin. J. Biol. Chem. 271:21–24.
Gimpl, G., K. Burger, and F. Fahrenholz. 1997. Cholesterol as modulator of re-
ceptor function. Biochemistry. 36:10959–10974.
Graf, J., Y. Iwamoto, M. Sasaki, G.R. Martin, H.K. Klienman, F.A. Robey, and
Y. Yamada. 1987a. Identification of an amino acid sequence in laminin me-
diating cell attachment, chemotaxis, and receptor binding. Cell. 48:989–996.
Graf, J., R.C. Ogle, F.A. Robey, M. Sasaki, G.R. Martin, Y. Yamada, and H.K.
Kleinman. 1987b. A pentapeptide from the laminin B1 chain mediates cell
adhesion and binds the 67,000 laminin receptor. Biochemistry. 26:6896–6900.
Gresham, H.D., S.P. Adams, and E.J. Brown. 1992. Ligand binding specificity
of the leukocyte response integrin expressed by human neutrophils. J. Biol.
Chem. 267:13895–13902.
Hermann, P., M. Armant, E. Brown, M. Rubio, H. Ishihara, D. Ulrich, R.G.
Caspary, F.P. Lindberg, R. Armitage, C. Maliszewski, et al. 1999. The vi-
tronectin receptor and its associated cd47 molecule mediates proinflamma-
tory cytokine synthesis in human monocytes by interaction with soluble
CD23.  J. Cell Biol. 144:767–775.
Hooper, N.M. 1998. Membrane biology: do glycolipid microdomains really ex-
ist? Curr. Biol. 8:R114–R116.
Iwamoto, Y., F.A. Robey, J. Graf, M. Sasaki, H.K. Kleinman, Y. Yamada, and
G.R. Martin. 1987. YIGSR, a synthetic laminin pentapeptide, inhibits exper-
imental metastasis formation. Science. 238:1132–1134.
Keller, P., and K. Simons. 1998. Cholesterol is required for surface transport of
influenza virus hemagglutinin. J. Cell Biol. 140:1357–1367.
Kerins, D.M., R. Murray, and G.A. FitzGerald. 1991. Prostacyclin and prosta-
glandin E1: molecular mechanisms and therapeutic utility. Prog. Hemostasis
Thromb. 10:307–337.
Klein, U., G. Gimpl, and F. Fahrenholz. 1995. Alteration of the myometrial
plasma membrane cholesterol content with beta-cyclodextrin modulates the
binding affinity of the oxytocin receptor. Biochemistry. 34:13784–13793.
Kosfeld, M.D., and W.A. Frazier. 1992. Identification of active peptide se-
quences in the carboxyl-terminal cell binding domain of human thrombo-
spondin-1. J. Biol. Chem. 267:16230–16236.
Kosfeld, M.D., and W.A. Frazier. 1993. Identification of a new cell adhesion
motif in two homologous peptides from the COOH-terminal cell binding do-
main of human thrombospondin. J. Biol. Chem. 268:8808–8814.
Kurzchalia, T.V., P. Dupree, R.G. Parton, R. Kellner, H. Virta, M. Lehnert,
and K. Simons. 1992. VIP21, a 21-kD membrane protein is an integral com-
ponent of trans-Golgi network-derived transport vesicles. J. Cell Biol. 118:
1003–1014.
Lindberg, F.P., H.D. Gresham, E. Schwarz, and E.J. Brown. 1993. Molecular
cloning of integrin-associated protein: an immunoglobulin family member
with multiple membrane spanning domains implicated in alpha-v, beta-
3-dependent ligand binding. J. Cell Biol. 123:485–496.
Lindberg, F.P., D.M. Lublin, M.J. Telen, R.A. Veile, Y.E. Miller, H. Donis-
Keller, and E.J. Brown. 1994. Rh-related antigen CD47 is the signal-trans-
ducer integrin associated protein. J. Biol. Chem. 269:1567–1570.
Lindberg, F.P., D.C. Bullard, T.E. Caver, H.D. Gresham, A.L. Beaudet, and
E.J. Brown. 1996a. Decreased resistance to bacterial infection and granulo-
cyte defects in IAP-deficient mice. Science. 274:795–798.
Lindberg, F.P., H.D. Gresham, M.I. Reinhold, and E.J. Brown. 1996b. Integrin-
associated protein immunoglobulin domain is necessary for efficient vi-
tronectin bead binding. J. Cell Biol. 134:1313–1322.
Mumby, S.M. 1997. Reversible palmitoylation of signaling proteins. Curr. Opin.
Cell Biol. 9:148–154.
Okamoto, T., A. Schlegel, P.E. Scherer, and M.P. Lisanti. 1998. Caveolins, a
family of scaffolding proteins for organizing “preassembled signaling com-
plexes” at the plasma membrane. J. Biol. Chem. 273:5419–5422.
Orlando, R.A., and D.A. Cheresh. 1991. Arginine-glycine-aspartic acid binding
leading to molecular stabilization between integrin alpha v beta 3 and its
ligand. J. Biol. Chem. 266:19543–19550.
Reinhold, M.I., F.P. Lindberg, D. Plas, S. Reynolds, M.G. Peters, and E.J.
Brown. 1995. In vivo expression of alternatively spliced forms of integrin-
associated protein (CD47). J. Cell Sci. 108:3419–3425.
Reinhold, M.I., F.P. Lindberg, G.J. Kersh, P.M. Allen, and E.J. Brown. 1997.
Costimulation of T cell activation by integrin-associated protein (CD47) is
an adhesion-dependent, CD28-independent signaling pathway. J. Exp. Med.
185:1–11.
Rodgers, W., and J.K. Rose. 1996. Exclusion of CD45 inhibits activity of p56lck
associated with glycolipid-enriched membrane domains. J. Cell Biol. 135:
1515–1523.
Rosales, C., H.D. Gresham, and E.J. Brown. 1992. Expression of the 50kD inte-
grin associated protein on myeloid cells and erythrocytes. J. Immunol. 149:
2759–2764.
Sargiacomo, M., M. Sudol, Z. Tang, and M.P. Lisanti. 1993. Signal transducing
molecules and glycosyl-phosphatidylinositol-linked proteins form a caveo-
lin-rich insoluble complex in MDCK cells. J. Cell Biol. 122:789–807.
Schwartz, M.A., E.J. Brown, and B. Fazeli. 1993. A 50 kDa integrin-associated
protein is required for integrin-regulated calcium entry in endothelial cells.
J. Biol. Chem. 268:19931–19934.
Senior, R.M., H.D. Gresham, G.L. Griffin, E.J. Brown, and A.E. Chung. 1992.
Entactin stimulates neutrophil adhesion and chemotaxis through interac-
tions between its Arg-Gly-Asp (RGD) domain and the leukocyte response
integrin (LRI). J. Clin. Invest. 90:2251–2257.
Sheets, E.D., D. Holowka, and B. Baird. 1999a. Critical role for cholesterol in
lyn-mediated tyrosine phosphorylation of FceRI and their association with
detergent-resistant membranes. J. Cell Biol. 145:877–887.
Sheets, E.D., D. Holowka, and B. Baird. 1999b. Membrane organization in im-
munoglobulin E receptor signaling. Curr. Opin. Chem. Biol. 3:95–99.
Simons, K., and E. Ikonen. 1997. Functional rafts in cell membranes. Nature.
387:569–572.
Van Strijp, J.A.G., D.G. Russell, E. Tuomanen, E.J. Brown, and S.D. Wright.
1993. Ligand specificity of purified complement receptor type 3 (CD11b/
CD18, Mac-1, alphaM beta2): indirect effects of an Arg-Gly-Asp sequence.
J. Immunol. 151:3324–3336.
Varma, R., and S. Mayor. 1998. GPI-anchored proteins are organized in submi-
cron domains at the cell surface. Nature. 394:798–801.
Wang, X.Q., and W.A. Frazier. 1998. The thrombospondin receptor CD47
(IAP) modulates and associates with alpha-2-beta-1 integrin in vascular
smooth muscle cells. Mol. Biol. Cell. 9:865–874.
Wayner, E.A., R.A. Orlando, and D.A. Cheresh. 1991. Integrins avb3 and
avb5 contribute to cell attachment to vitronectin but differentially distribute
on the cell surface. J. Cell Biol. 113:919–929.
Woodward, D.F., J.W. Regan, S. Lake, and A. Ocklind. 1997. The molecular bi-
ology and ocular distribution of prostanoid receptors. Surv. Ophthalmol. 41:
S15–S21.
Xavier, R., T. Brennan, Q. Li, C. McCormack, and B. Seed. 1998. Membrane com-
partmentation is required for efficient T cell activation. Immunity. 8:723–732.
Zhang, W., R.P. Trible, and L.E. Samelson. 1998. LAT palmitoylation: its es-
sential role in membrane microdomain targeting and tyrosine phosphoryla-
tion during T cell activation. Immunity. 9:239–246.
Zhou, M.-J., and E.J. Brown. 1993. Leukocyte response integrin and integrin
associated protein act as a signal transduction unit in generation of a phago-
cyte respiratory burst. J. Exp. Med. 178:1165–1174.